Media

CARISMA Therapeutics Announces First Patient Dosed in Landmark Clinical Study Evaluating Engineered Macrophages in Humans

Doctrin Launches Solution for Integrated Healthcare

Nordic Nanovector Appoints Experienced Pharmaceutical Company Leader Peter L. Braun as Chief Executive Officer

Spruce Biosciences Presents Phase 1 and 2 Data for Tildacerfont in Adults with Congenital Adrenal Hyperplasia from Endocrine Society’s 2021 Annual Meeting

Orexo continues to strengthen IP rights for ZUBSOLV®

Aprea Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Update on Business Operations

Orexo publishes prospectus and applies for admission to trading of corporate bonds

Oncopeptides announces that the first patients in the United States are being treated with PEPAXTO®

Vicore Pharma’s drug candidate C21 dilates peripheral resistance vessels in fibrotic disease